InvestorsHub Logo
Followers 5
Posts 480
Boards Moderated 0
Alias Born 05/01/2019

Re: None

Friday, 05/26/2023 1:01:58 PM

Friday, May 26, 2023 1:01:58 PM

Post# of 13843
I have a feeling we will soon learn that UHP has abandoned their quest to produce Hemostyp in the USA. Hence, the emphasis that now the Cutting and packaging is happening in a USA plant, not the manufacturing.
Could be wrong (doubtful) but Either way, using two facilities seems like a logistical nightmare for a company like UHP and it is my assumption that this is a huge part of why the testing has returned unsatisfactory results which they essentially admitted.
These changes wreak havoc on the original PMA and were the reasons I stated repeatedly that major amendments were needed.

Just for weekendBBQ UEEC talking points. Hot take predictions:

$2-3.50 With PMA
12+ months to PMA decision
24 months to acquisition.

In the mean time UHP May be presented a low ball offer of approximately $0.48.

This excludes potential pump and dumps.

Have a tremendous weekend. And RELAX a little.